4.4 Article

Adverse events following immunization with vaccines containing adjuvants

Related references

Note: Only part of the references are listed.
Review Rheumatology

Infections and vaccines in the etiology of antiphospholipid syndrome

Paola Cruz-Tapias et al.

CURRENT OPINION IN RHEUMATOLOGY (2012)

Editorial Material Immunology

Vaccine adjuvants: is the pipeline clogged?

Wolfgang W. Leitner

IMMUNOTHERAPY (2012)

Article Rheumatology

Macrophagic myofasciitis: characterization and pathophysiology

R. K. Gherardi et al.

LUPUS (2012)

Article Psychology, Developmental

Thimerosal Exposure in Early Life and Neuropsychological Outcomes 7-10 Years Later

John P. Barile et al.

JOURNAL OF PEDIATRIC PSYCHOLOGY (2012)

Review Immunology

Trends in vaccine adjuvants

Virgil E. J. C. Schijns et al.

EXPERT REVIEW OF VACCINES (2011)

Review Immunology

'ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants

Yehuda Shoenfeld et al.

JOURNAL OF AUTOIMMUNITY (2011)

Review Pharmacology & Pharmacy

Influenza Vaccine and Adjuvant

Tetsuo Nakayama

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2011)

Review Immunology

The immunobiology of aluminium adjuvants: how do they really work?

Christopher Exley et al.

TRENDS IN IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

Stephanie C. Eisenbarth et al.

NATURE (2008)

Review Immunology

The science of adjuvants

Marcin Kwissa et al.

EXPERT REVIEW OF VACCINES (2007)

Article Biochemistry & Molecular Biology

Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture

WJ Lukiw et al.

JOURNAL OF INORGANIC BIOCHEMISTRY (2005)